Status: current, Primitive. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 174119011000036112 | liposomal amphotericin B | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 174120011000036113 | liposomal amphotericin B (AU substance) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| liposomal amphotericin B | is modification of | amphotericin B | true | Inferred relationship | Some | ||
| liposomal amphotericin B | Is a | medicinal substance | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Ambisome 50 mg powder for injection, 50 mg vial | has intended active ingredient | True | liposomal amphotericin B | Inferred relationship | Some | 160109958 |
| liposomal amphotericin B | has intended active ingredient | True | liposomal amphotericin B | Inferred relationship | Some | 1 |
| amphotericin B (as liposomal) 50 mg injection, vial | has intended active ingredient | True | liposomal amphotericin B | Inferred relationship | Some | 1756678554 |
This concept is not in any reference sets
FHIR